Loading...
  • gels
  • The newer drug forms, on which in recent years research has been conducted in order to achieve a controlled release of drug to eyeball tissues, include multicompartment carrier systems, inserts, collagen shields, contact lenses, and the so-called in situ gels [ 1 - 3 , 5 ]. (hindawi.com)
  • pharmaceutical
  • The application discloses a process for making a polymeric powder which is readily dispersible in water to provide a composition useful for forming an enteric coating on pharmaceutical dosage forms and also a process for using the powder for its intended purpose. (google.es)
  • 1. A process of making a polymeric powder which is readily dispersible in water to provide a composition useful for forming an entric coating on pharmaceutical dosage forms, comprising providing a freshly prepared aqueous dispersion of spherical water-insoluble enteric polymer particles, adding to said dispersion a phosphate salt in an amount sufficient to minimize coalescense of the particles during spray drying, thoroughly mixing, and spray drying to form the powder. (google.es)
  • 8. The process set forth in claim 7 comprising the additional steps of dispersing the spray dried powder in water, adding a plasticizer in an amount of between 10% and 40% of the weight of the dry polymer to form a coating composition, and coating a pharmaceutical dosage form therewith. (google.es)
  • 17. The process set forth in claim 16 comprising the additional steps of dispersing the spray dried powder in water, adding a plasticizer in an amount of between 10% and 40% of the weight of the cellulose acetate phthalate particles to form a coating composition, and coating a pharmaceutical dosage form therewith. (google.es)
  • Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. (curehunter.com)
  • medicinal
  • The main reason of continuingly strong interest of scientists in these drug forms is the problem of a low bioavailability of medicinal substance after the application to the eyeball. (hindawi.com)
  • suspensions
  • Eye drops are accessible in the forms of water and oil solutions, emulsions, or suspensions of one or more active ingredients, which may contain preservatives if stored in multiuse packaging. (hindawi.com)
  • complexes
  • The formed complexes and the site of interaction were examined by UV/VIS, IR, and 1 H-NMR techniques, and computational molecular modeling. (hindawi.com)
  • wherein
  • 2. The dosage form of claim 1 , wherein a portion of the shell in contact with said first core is adapted to be breached before a portion of the shell in contact with said second core. (google.com.au)
  • 6. The dosage form of claim 5 , wherein said first and second cores have different shapes. (google.com.au)
  • 9. The dosage form of claim 5 , wherein the topography of the shell at a location proximal to said first core is different from the topography of the shell at a location proximal to said second core. (google.com.au)
  • 15. The dosage form of claim 1 , wherein said first and second cores each comprise upper and lower faces, and the first shell portion is in contact with the upper faces of said first and second cores, and the second shell portion is in contact with the lower faces of said first and second cores. (google.com.au)
  • 3. The method of claim 1 , wherein the method is repeated to prepare individualized dosage forms for at least two individual patients. (google.com)
  • wherein the solid matrix and the deposited neramexane, a pharmaceutically acceptable salt, solvate, conjugate, prodrug, polymorphic form, isomer or derivative are coated with the at least one release-controlling excipient. (freepatentsonline.com)
  • thus
  • By subjecting the thus coated units to heating to accelerate the formation of a continuous phase of the film-forming agent of the inner layer and optionally also of the additional substance, a coating is formed which substantially does not change its diffusion characteristics in the course of time. (google.com.au)
  • provides
  • The dosage form provides a delay of at least one hour between the initial release of active ingredient contained in said first core and the initial release. (google.com.au)
  • patient
  • Asian J Pharm 2008;2:91-5, European Patent EP0948332) 2) Nail lacquer ( http://www.patient.co.uk/medicine/Amorolfine-nail-lacquer.htm ) 3) Chewing gums ( http://www.usp.org/pdf/EN/USPNF/Vol34No3Stimuli2.pdf ) I hope this links will highlight few aspects of other unusual dosage form. (pharmainfo.net)